IDEAYA Biosciences, Inc. IDYA
- darovasertib — Metastatic Uveal Melanoma NDA Submitted
- darovasertib — Uveal Melanoma Phase 3
GNAQ (1 companies · 2 programs)
Companies with an active program directed at GNAQ.
Companies with an active program directed at GNAQ.